OSSIAM

Position in NBIX — Neurocrine Biosciences Inc

CIK 1767471 PARIS, I0

Position in NBIX

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$176,795

-$12,973 QoQ

Shares Held

1,342

+0.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OSSIAM holds $12,322,084 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	126,199	$3,846,545
2	ANIP	Ani Pharmaceuticals Inc	47,400	$3,645,060
3	PBH	Prestige Consumer Healthcare Inc.	43,300	$2,566,391
4	ZTS	Zoetis Inc.	13,925	$1,646,074
5	UTHR	UNITED THERAPEUTICS Corp	622	$368,833
6	NBIX	Neurocrine Biosciences Inc This page	1,342	$176,795
7	VTRS	Viatris Inc	5,358	$72,386

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$176,795	1,342	+0.3%	Shares	Defined	2026-05-14
2025-12-31	$189,768	1,338	-39.2%	Shares	Defined	2026-02-13
2025-09-30	$308,976	2,201	-26.4%	Shares	Defined	2025-11-14
2025-06-30	$375,687	2,989	0.0%	Shares	Defined	2025-08-13
2025-03-31	$330,583	2,989	-14.2%	Shares	Defined	2025-05-14
2024-12-31	$475,702	3,485	+16.1%	Shares	Defined	2025-02-13
2024-09-30	$345,775	3,001	+3271.9%	Shares	Defined	2024-11-13
2024-06-30	$12,252	89	-98.3%	Shares	Defined	2024-08-13
2023-12-31	$708,341	5,376	+12.9%	Shares	Defined	2024-02-13
2023-09-30	$535,725	4,762	+49.6%	Shares	Defined	2023-11-14
2023-06-30	$300,156	3,183	+136.0%	Shares	Defined	2023-08-11
2023-03-31	$136,545	1,349	+80.8%	Shares	Defined	2023-05-12
2022-12-31	$89,102	746	0.0%	Shares	Defined	2023-02-13
2022-09-30	$79,232	746	—	Shares	Defined	2022-11-14
No filing history on record for this holder in this stock.